A trial looking at rilvegostomig and chemotherapy for advanced non small cell lung cancer (ARTEMIDE-Lung03)

This trial is looking at rilvegostomig and chemotherapy for non small cell lung cancer that has spread. It is comparing this to having pembrolizumab and chemotherapy.

It is for people who:

• have a type of non small cell lung cancer called non squamous cell

• are having their first treatment for cancer that has spread to another part of the body

• have cancer cells with a protein called PD-L1

You pronounce rilvegostomig as ril–veh–gost-oh-mig.